Find Mefenamic Acid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

69RELATED EXCIPIENT COMPANIES

106EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 61-68-7, Ponstel, 2-[(2,3-dimethylphenyl)amino]benzoic acid, Mephenamic acid, Mephenaminic acid, Ponstan
Molecular Formula
C15H15NO2
Molecular Weight
241.28  g/mol
InChI Key
HYYBABOKPJLUIN-UHFFFAOYSA-N
FDA UNII
367589PJ2C

Mefenamic Acid
A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
Mefenamic acid is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of mefenamic acid is as a Cyclooxygenase Inhibitor.
1 2D Structure

Mefenamic Acid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(2,3-dimethylanilino)benzoic acid
2.1.2 InChI
InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)
2.1.3 InChI Key
HYYBABOKPJLUIN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
2.2 Other Identifiers
2.2.1 UNII
367589PJ2C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Acid, Mefenamic

2. Apo Mefenamic

3. Apo-mefenamic

4. Contraflam

5. Coslan

6. Dysman

7. Mefac

8. Mefacit

9. Mefenaminic Acid

10. Mefic

11. Nu Mefenamic

12. Nu-mefenamic

13. Parkemed

14. Pinalgesic

15. Pms Mefenamic Acid

16. Pms-mefenamic Acid

17. Ponalar

18. Ponalgic

19. Ponmel

20. Ponstan

21. Ponstan Forte

22. Ponstel

23. Ponsyl

24. Pontal

2.3.2 Depositor-Supplied Synonyms

1. 61-68-7

2. Ponstel

3. 2-[(2,3-dimethylphenyl)amino]benzoic Acid

4. Mephenamic Acid

5. Mephenaminic Acid

6. Ponstan

7. 2-((2,3-dimethylphenyl)amino)benzoic Acid

8. Parkemed

9. Coslan

10. Mefacit

11. Ponalar

12. Methenamic Acid

13. Mefenaminsaeure

14. Bonabol

15. Lysalgo

16. Tanston

17. Vialidon

18. Bafameritin-m

19. Tamany Bonsan

20. Ponstan Forte

21. Acide Mefenamique

22. Namphen

23. Pontal

24. Mefanamic Acid

25. Bafhameritin-m

26. Cn-35355

27. N-2,3-xylylanthranilic Acid

28. 2-(2,3-dimethylanilino)benzoic Acid

29. Mefenamate

30. Mefenacid

31. Ponstil

32. Ponstyl

33. Mefenaminic Acid

34. Hl 1

35. Inf-3355

36. Inf 3355

37. Acido Mefenamico

38. Ci-473

39. N-(2,3-xylyl)anthranilic Acid

40. Acidum Mefenamicum

41. N-(2,3-xylyl)-2-aminobenzoic Acid

42. N-(2,3-dimethylphenyl)anthranilic Acid

43. Agn-1255

44. Cl 473

45. Gardan

46. Benzoic Acid, 2-[(2,3-dimethylphenyl)amino]-

47. 2-(2,3-dimethylphenylamino)benzoic Acid

48. Anthranilic Acid, N-2,3-xylyl-

49. Cn 35355

50. Nsc 94437

51. Benzoic Acid, 2-((2,3-dimethylphenyl)amino)-

52. Ci 473

53. Nsc-94437

54. 2-diphenylaminecarboxylic Acid, 2',3'-dimethyl-

55. Chembl686

56. Mls000069709

57. Chebi:6717

58. Benzoic Acid, 2-(2,3-dimethylphenyl)amino-

59. M01ag01

60. Nsc94437

61. 367589pj2c

62. J2.344b

63. Cas-61-68-7

64. Ncgc00016278-07

65. Smr000058188

66. Dsstox_cid_3243

67. Mefenaminsaeure [german]

68. Dsstox_rid_76938

69. Dsstox_gsid_23243

70. Ac. Mefenamico [italian]

71. In-m

72. Acide Mefenamique [french]

73. Acide Mefenamique [inn-french]

74. Acido Mefenamico [inn-spanish]

75. Acidum Mefenamicum [inn-latin]

76. 2-(2,3-xylidino)benzoic Acid

77. Hsdb 3115

78. Sr-01000000216

79. Einecs 200-513-1

80. Mfcd00051721

81. Brn 2216243

82. Mefenamic-acid

83. Unii-367589pj2c

84. Prestwick_506

85. Anthranilic Acid, N-(2,3-xylyl)-

86. Mefenamic Acid,(s)

87. Spectrum_000174

88. Cpd000058188

89. Opera_id_542

90. Mefenamic Acid [usan:usp:inn:ban:jan]

91. Prestwick0_000054

92. Prestwick1_000054

93. Prestwick2_000054

94. Prestwick3_000054

95. Spectrum2_001941

96. Spectrum3_001082

97. Spectrum4_001235

98. Spectrum5_001341

99. M1782

100. Anthranilic Acid,3-xylyl-

101. Cid_4044

102. Schembl3544

103. Mefenamic Acid [mi]

104. Oprea1_193889

105. Bspbio_000207

106. Bspbio_002724

107. Kbiogr_001730

108. Kbioss_000654

109. Mefenamic Acid [inn]

110. Mefenamic Acid [jan]

111. Mls001074162

112. Divk1c_000298

113. Mefenamic Acid [hsdb]

114. Mefenamic Acid [usan]

115. Spectrum1501103

116. Spbio_002001

117. Spbio_002128

118. Mefenamic Acid [vandf]

119. Bpbio1_000229

120. F0850-6853

121. Gtpl2593

122. Sgcut00005

123. Wln: Qvr Bmr B1 C1

124. Mefenamic Acid [mart.]

125. Dtxsid5023243

126. Mefenamic Acid [usp-rs]

127. Mefenamic Acid [who-dd]

128. Hms500o20

129. Kbio1_000298

130. Kbio2_000654

131. Kbio2_003222

132. Kbio2_005790

133. Kbio3_001944

134. Zinc20241

135. Brd8217

136. Ninds_000298

137. Hms1568k09

138. Hms1921d13

139. Hms2090b07

140. Hms2092b17

141. Hms2095k09

142. Hms2232p18

143. Hms3259m19

144. Hms3370k18

145. Hms3652a10

146. Hms3712k09

147. Hms3885o22

148. Pharmakon1600-01501103

149. Mefenamic Acid (jp17/usp/inn)

150. Mefenamic Acid, Analytical Standard

151. Albb-025759

152. Bcp08499

153. Brd-8217

154. Hy-b0574

155. To_000071

156. Tox21_110344

157. Tox21_301983

158. Bbl003564

159. Bdbm50134036

160. Ccg-39434

161. Mefenamic Acid [orange Book]

162. Nsc757834

163. S4078

164. Stk666691

165. Mefenamic Acid [ep Monograph]

166. Akos001025551

167. Akos002388313

168. Benzoic Acid,3-dimethylphenyl)amino]-

169. Mefenamic Acid [usp Monograph]

170. Tox21_110344_1

171. Db00784

172. Nc00517

173. Nsc-757834

174. Idi1_000298

175. Smp2_000141

176. 2-(2,3-dimethylanilino)benzoic Acid #

177. 2-(2,3-dimethylphenyl)aminobenzoic Acid

178. Ncgc00016278-01

179. Ncgc00016278-02

180. Ncgc00016278-03

181. Ncgc00016278-04

182. Ncgc00016278-05

183. Ncgc00016278-06

184. Ncgc00016278-10

185. Ncgc00022393-03

186. Ncgc00022393-04

187. Ncgc00022393-05

188. Ncgc00255401-01

189. Ac-11160

190. As-12677

191. Sbi-0051636.p002

192. 2-(2,3-dimethyl-phenylamino)-benzoic Acid

193. 2-[(2,3-dimethylphenyl) Amino]benzoic Acid

194. 2-diphenylaminecarboxylic Acid,3'-dimethyl-

195. Ab00052200

196. Am20060688

197. Ft-0628184

198. Sw196700-3

199. Unm000001233403

200. 1-methyl-3-benzylimidazolium Tetrafluoroborate

201. C02168

202. D00151

203. Ab00052200-17

204. Ab00052200_18

205. Ab00052200_19

206. A833367

207. Q284321

208. 2-(2,3-dimethylanilino)benzoic Acid;mefenamic Acid

209. Sr-01000000216-2

210. Sr-01000000216-4

211. W-105113

212. Brd-k92778217-001-06-1

213. Z56755828

214. 2-(2,3-dimethyl-phenylamino)-benzoic Acid(mefenamic Acid)

215. Mefenamic Acid, European Pharmacopoeia (ep) Reference Standard

216. Mefenamic Acid, United States Pharmacopeia (usp) Reference Standard

217. 4-methyl-n-(3-{3-[(4-methylpiperidin-1-yl)carbonyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)benzenesulfonamide

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 241.28 g/mol
Molecular Formula C15H15NO2
XLogP35.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass241.110278721 g/mol
Monoisotopic Mass241.110278721 g/mol
Topological Polar Surface Area49.3 Ų
Heavy Atom Count18
Formal Charge0
Complexity292
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameMefenamic acid
PubMed HealthMefenamic Acid (By mouth)
Drug ClassesAnalgesic, Antimigraine, Central Nervous System Agent
Drug LabelMefenamic acid is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). Each Size 1 Yellow-Yellow capsule, with PAD imprinted on the cap & 195 imprinted on the body, contains 250 mg of mefenamic acid for o...
Active IngredientMefenamic acid
Dosage FormCapsule
RouteOral
Strength250mg
Market StatusPrescription
CompanyVintage Pharms; Breckenridge Pharm; Lupin; Micro Labs

2 of 4  
Drug NamePonstel
PubMed HealthMefenamic Acid (By mouth)
Drug ClassesAnalgesic, Antimigraine, Central Nervous System Agent
Drug LabelPONSTEL (mefenamic acid) is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). Each blue-banded, ivory capsule contains 250 mg of mefenamic acid for oral administration. Mefenamic acid is a white to greyish-white, odor...
Active IngredientMefenamic acid
Dosage FormCapsule
RouteOral
Strength250mg
Market StatusPrescription
CompanyShionogi

3 of 4  
Drug NameMefenamic acid
PubMed HealthMefenamic Acid (By mouth)
Drug ClassesAnalgesic, Antimigraine, Central Nervous System Agent
Drug LabelMefenamic acid is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). Each Size 1 Yellow-Yellow capsule, with PAD imprinted on the cap & 195 imprinted on the body, contains 250 mg of mefenamic acid for o...
Active IngredientMefenamic acid
Dosage FormCapsule
RouteOral
Strength250mg
Market StatusPrescription
CompanyVintage Pharms; Breckenridge Pharm; Lupin; Micro Labs

4 of 4  
Drug NamePonstel
PubMed HealthMefenamic Acid (By mouth)
Drug ClassesAnalgesic, Antimigraine, Central Nervous System Agent
Drug LabelPONSTEL (mefenamic acid) is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). Each blue-banded, ivory capsule contains 250 mg of mefenamic acid for oral administration. Mefenamic acid is a white to greyish-white, odor...
Active IngredientMefenamic acid
Dosage FormCapsule
RouteOral
Strength250mg
Market StatusPrescription
CompanyShionogi

4.2 Therapeutic Uses

Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


MEFENAMIC ACID (PONSTEL) ... PROVIDES ANALGESIA IN MAN SIMILAR TO THAT PRODUCED BY ASPIRIN.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 343


...INDICATED FOR RELIEF OF PAIN RESULTING FROM DENTAL EXTRACTIONS.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1050


DRUG PREFERABLY SHOULD BE TAKEN WITH FOOD.

American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 349


MEFENAMIC ACID SHOWED FAVORABLE RESULTS RELATIVE TO SOME ANALGESICS.

ANDERSON ET AL; TRIAL OF PROSTAGLANDIN SYNTHETASE INHIBITORS IN PRIMARY DYSMENORRHEA; LANCET 1(FEB 18) 345-348 (1978)


4.3 Drug Warning

SINCE IT IS NOT SUPERIOR TO ESTABLISHED ANALGESICS & CAN CAUSE SERIOUS TOXICITY, USE OF MEFENAMIC ACID IS NOT RECOMMENDED. IF IT IS USED, ADMIN SHOULD NOT BE EXTENDED BEYOND 7 DAYS. IF DIARRHEA OCCURS, DRUG MUST BE DISCONTINUED & NOT USED AGAIN. IT SHOULD NOT BE USED IN CHILDREN OR IN WOMEN OF CHILDBEARING AGE.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 343


IT IS CONTRAINDICATED IN PT WITH ULCERATION OF UPPER OR LOWER INTESTINAL TRACT...& PT KNOWN TO BE HYPERSENSITIVE TO DRUG. ...CONSIDER ITS USE ONLY IN CASES WHICH EITHER CAN NOT TOLERATE OR DO NOT RESPOND TO LESS TOXIC AGENTS.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1050


MEFENAMIC ACID IS CONTRAINDICATED IN PT...WITH IMPAIRED RENAL FUNCTION, & SHOULD BE USED WITH CAUTION IN ASTHMATICS BECAUSE IT MAY EXACERBATE CONDITION.

American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 349


Maternal Medication usually Compatible with Breast-Feeding: Mefenamic acid: Reported Sign or Symptom in Infant or Effect on Lactation: None. /from Table 6/

Report of the American Academy of Pediatrics Committee on Drugs in Pediatrics 93 (1): 141 (1994)


4.4 Drug Indication

For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.


5.2 MeSH Pharmacological Classification

Cyclooxygenase Inhibitors

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)


Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
MEFENAMIC ACID
5.3.2 FDA UNII
367589PJ2C
5.3.3 Pharmacological Classes
Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Anti-Inflammatory Agents, Non-Steroidal [CS]
5.4 ATC Code

M - Musculo-skeletal system

M01 - Antiinflammatory and antirheumatic products

M01A - Antiinflammatory and antirheumatic products, non-steroids

M01AG - Fenamates

M01AG01 - Mefenamic acid


5.5 Absorption, Distribution and Excretion

Absorption

Mefenamic acid is rapidly absorbed after oral administration.


Route of Elimination

The fecal route of elimination accounts for up to 20% of the dose, mainly in the form of unconjugated 3-carboxymefenamic acid.3 The elimination half-life of mefenamic acid is approximately two hours. Mefenamic acid, its metabolites and conjugates are primarily excreted by the kidneys. Both renal and hepatic excretion are significant pathways of elimination.


Volume of Distribution

1.06 L/kg [Normal Healthy Adults (18-45 yr)]


Clearance

Oral cl=21.23 L/hr [Healthy adults (18-45 yrs)]


CROSSES PLACENTAL BARRIER IN MONKEYS...EXCRETED IN URINE, BILE &/OR FECES...

American Society of Hospital Pharmacists. Data supplied on contract from American Hospital Formulary Service and other current ASHP sources., p. 1967


ABSORBED SLOWLY FROM GI TRACT...HIGH PERCENTAGE...BOUND TO PLASMA PROTEINS. PEAK PLASMA LEVELS APPEAR IN 2 TO 4 HR...ANALGESIA MAY PERSIST FOR UP TO 6 HR...ABOUT 50%...IS EXCRETED IN URINE WITHIN 24 HR /HUMAN, ORAL/

American Society of Hospital Pharmacists. Data supplied on contract from American Hospital Formulary Service and other current ASHP sources., p. 1967


5.6 Metabolism/Metabolites

Mefenamic acid undergoes metabolism by CYP2C9 to 3-hydroxymethyl mefenamic acid, and further oxidation to a 3-carboxymefenamic acid may occur. The activity of these metabolites has not been studied. Mefenamic acid is also glucuronidated directly.


MEFENAMIC ACID...IS TRANSFORMED TO HYDROXYMETHYL DERIVATIVE & TO ACID BY MAJOR, IF NOT ONLY, METABOLIC PATHWAY IN DOG, MONKEY, & HUMAN.

Testa, B. and P. Jenner. Drug Metabolism: Chemical & Biochemical Aspects. New York: Marcel Dekker, Inc., 1976., p. 12


Mefenamic acid has known human metabolites that include 3-hydroxymethyl mefenamic aci.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.7 Biological Half-Life

2 hours


...ABOUT 50%...IS EXCRETED IN URINE WITHIN 24 HR /HUMAN, ORAL/

American Society of Hospital Pharmacists. Data supplied on contract from American Hospital Formulary Service and other current ASHP sources., p. 1967


5.8 Mechanism of Action

Mefenamic acid binds the prostaglandin synthetase receptors COX-1 and COX-2, inhibiting the action of prostaglandin synthetase. As these receptors have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity, the symptoms of pain are temporarily reduced.


API SUPPLIERS

read-more
read-more

01

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

02

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

03

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, MX arrow-down AUDIT
HRV Global Life Sciences

04

Zeon Pharma Industries India Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zeon Pharma Industries India Pvt Ltd

05

Vital Laboratories Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVital Laboratories – Trusted Global API Manufacturer of Quinine, Hyoscine, Antimalarials & Vitamins

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF MX arrow-down AUDIT
CB

06

Cerata Pharmaceuticals LLP

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCerata Pharmaceuticals LLP: WHO-GMP Certified Leading Manufacturer & Exporter of Steroid-Hormone & Peptide APIs From India.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

07

Nira Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

Nira Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

08

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

09

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

10

Souvin Pharmaceuticals Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

Souvin Pharmaceuticals Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Mefenamic Acid

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Mefenamic Acid

About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Jai Radhe Sales

03

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Mefenamic Acid

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content

Mefenamic Acid

About the Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herba...

Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herbal extracts, semi-finished granules, and finished formulations such as tablets, capsules, and dry suspensions. The company also provides product support through associate manufacturing plants for APIs, pellets, excipients, enzymes, and specialized chemicals, operating in compliance with cGMP, WHO-GMP, and EU-GMP standards. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Zeon Pharma Industries India Pvt Ltd

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVital Laboratories – Trusted Global API Manufacturer of Quinine, Hyoscine, Antimalarials & Vitamins

Flag India
Digital Content Digital Content

Mefenamic Acid

About the Company : Vital Laboratories is an API and intermediates manufacturer established in 1998, beginning with quinine derivatives. Today, it is a global leader in quinine and hyoscine derivative...

Vital Laboratories is an API and intermediates manufacturer established in 1998, beginning with quinine derivatives. Today, it is a global leader in quinine and hyoscine derivatives, antimalarials, and vitamins, offering over 60 synthetic and phytochemistry-based APIs. With backward integration from KSMs and two WHO GMP–approved manufacturing facilities in Vapi, India, accredited by leading global regulators, Vital delivers scale, efficiency, cost leadership, and reliable global supply security. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
CB

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCerata Pharmaceuticals LLP: WHO-GMP Certified Leading Manufacturer & Exporter of Steroid-Hormone & Peptide APIs From India.

Flag India
Digital Content Digital Content

Mefenamic Acid

About the Company : Cerata Pharmaceuticals LLP is a WHO-GMP certified pharmaceutical API manufacturer based in Gujarat, India. We specialize in the development and manufacturing of high-quality APIs a...

Cerata Pharmaceuticals LLP is a WHO-GMP certified pharmaceutical API manufacturer based in Gujarat, India. We specialize in the development and manufacturing of high-quality APIs and High Potency APIs, adhering to the highest global quality and compliance standards. As a fully integrated company, Cerata supports the complete API lifecycle from development to commercialization. Our products are trusted by pharmaceutical companies in over 40 countries, reflecting our strong global presence and commitment to excellence. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

07

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Mefenamic Acid

About the Company : DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We b...

DONGBANG FTL was founded in 1990 with the objective to become the most renowned and trusted company in the Active Pharmaceutical Ingredients industry through fair competition. We believe that providing people with quality-assured pharmaceutical products is one of the most effective ways to contribute towards 'happiness and health of humanity' and hence have been trying our utmost best to achieve our goal.
blank

08

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Mefenamic Acid

About the Company : Nira Life Sciences Pvt Ltd was initially established in 2012 at GIDC Bamanbore, Taluka- Chotila, District- Surendranagar, Gujarat, India. We stand out as a rapidly expanding pharma...

Nira Life Sciences Pvt Ltd was initially established in 2012 at GIDC Bamanbore, Taluka- Chotila, District- Surendranagar, Gujarat, India. We stand out as a rapidly expanding pharmaceutical enterprise in India, focusing on top-notch Pharmaceutical APIs and intermediates. Equipped with state-of-the-art facilities, we adhere to stringent standards including WHO – cGMP & ISO 9001:2015, and boast an exemplary compliance track record following numerous inspections by regulatory authorities.
blank

09

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Mefenamic Acid

About the Company : Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API e...

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.
blank

10

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Mefenamic Acid

About the Company : Sudarshan Pharma operates in the pharmaceutical and specialty chemicals industries. Their specialty chemicals and intermediates are used in pharma, paint, food, and adhesive sector...

Sudarshan Pharma operates in the pharmaceutical and specialty chemicals industries. Their specialty chemicals and intermediates are used in pharma, paint, food, and adhesive sectors. The company has a strong presence in both India and international markets, exporting products to the UK, Australia, Uzbekistan, Syria, Oman, Taiwan, and the MENA regions.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Empty Capsules

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 61-68-7 / Mefenamic Acid API manufacturers, exporters & distributors?

Mefenamic Acid manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Mefenamic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mefenamic Acid manufacturer or Mefenamic Acid supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mefenamic Acid manufacturer or Mefenamic Acid supplier.

API | Excipient name

Mefenamic Acid

Synonyms

61-68-7, Ponstel, 2-[(2,3-dimethylphenyl)amino]benzoic acid, Mephenamic acid, Mephenaminic acid, Ponstan

Cas Number

61-68-7

Unique Ingredient Identifier (UNII)

367589PJ2C

About Mefenamic Acid

A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.

Mefenamate Manufacturers

A Mefenamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mefenamate, including repackagers and relabelers. The FDA regulates Mefenamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mefenamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mefenamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Mefenamate Suppliers

A Mefenamate supplier is an individual or a company that provides Mefenamate active pharmaceutical ingredient (API) or Mefenamate finished formulations upon request. The Mefenamate suppliers may include Mefenamate API manufacturers, exporters, distributors and traders.

click here to find a list of Mefenamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Mefenamate USDMF

A Mefenamate DMF (Drug Master File) is a document detailing the whole manufacturing process of Mefenamate active pharmaceutical ingredient (API) in detail. Different forms of Mefenamate DMFs exist exist since differing nations have different regulations, such as Mefenamate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Mefenamate DMF submitted to regulatory agencies in the US is known as a USDMF. Mefenamate USDMF includes data on Mefenamate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mefenamate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Mefenamate suppliers with USDMF on PharmaCompass.

Mefenamate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Mefenamate Drug Master File in Japan (Mefenamate JDMF) empowers Mefenamate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Mefenamate JDMF during the approval evaluation for pharmaceutical products. At the time of Mefenamate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Mefenamate suppliers with JDMF on PharmaCompass.

Mefenamate KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Mefenamate Drug Master File in Korea (Mefenamate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mefenamate. The MFDS reviews the Mefenamate KDMF as part of the drug registration process and uses the information provided in the Mefenamate KDMF to evaluate the safety and efficacy of the drug.

After submitting a Mefenamate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mefenamate API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Mefenamate suppliers with KDMF on PharmaCompass.

Mefenamate CEP

A Mefenamate CEP of the European Pharmacopoeia monograph is often referred to as a Mefenamate Certificate of Suitability (COS). The purpose of a Mefenamate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mefenamate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mefenamate to their clients by showing that a Mefenamate CEP has been issued for it. The manufacturer submits a Mefenamate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mefenamate CEP holder for the record. Additionally, the data presented in the Mefenamate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mefenamate DMF.

A Mefenamate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mefenamate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Mefenamate suppliers with CEP (COS) on PharmaCompass.

Mefenamate WC

A Mefenamate written confirmation (Mefenamate WC) is an official document issued by a regulatory agency to a Mefenamate manufacturer, verifying that the manufacturing facility of a Mefenamate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mefenamate APIs or Mefenamate finished pharmaceutical products to another nation, regulatory agencies frequently require a Mefenamate WC (written confirmation) as part of the regulatory process.

click here to find a list of Mefenamate suppliers with Written Confirmation (WC) on PharmaCompass.

Mefenamate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mefenamate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Mefenamate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Mefenamate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Mefenamate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mefenamate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Mefenamate suppliers with NDC on PharmaCompass.

Mefenamate GMP

Mefenamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Mefenamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mefenamate GMP manufacturer or Mefenamate GMP API supplier for your needs.

Mefenamate CoA

A Mefenamate CoA (Certificate of Analysis) is a formal document that attests to Mefenamate's compliance with Mefenamate specifications and serves as a tool for batch-level quality control.

Mefenamate CoA mostly includes findings from lab analyses of a specific batch. For each Mefenamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Mefenamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mefenamate EP), Mefenamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mefenamate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty